国际浆膜腔液细胞病理学系统用于脑脊液诊断及流式细胞术辅助分析
本研究回顾性纳入2023年854例脑脊液细胞学标本,按国际浆膜腔液细胞病理学系统(TIS)分为五类并计算恶性风险。结果显示TIS分类可标准化报告术语、提供风险分层,联合流式细胞术有助于减少不确定诊断。
要点
- TIS五分类的恶性风险分别为:NFM 0.3%、AUS 4.5%、SFM 66.7%、MAL 100%。
- TIS用于脑脊液细胞学诊断灵敏度95%、特异度100%、准确率99%。
- 流式细胞术联合细胞学有助于减少不确定诊断,尤其病因不明或有血液肿瘤史者。
核心结论
- 将TIS应用于脑脊液标本有助于标准化报告术语、提高诊断准确性并提供预测性风险分层。
- 细胞学联合流式细胞术有助于减少不确定诊断,尤其对病因不明或既往有血液系统恶性肿瘤史者。
研究设计与样本
- 基于细胞形态学与流式细胞术结果,按TIS将病例重新分类为ND、NFM、AUS、SFM和MAL五类。
- 185例(21.7%)进行了流式细胞术检测,其中23例结果阳性。
主要发现
- 应用TIS后最终细胞学诊断分布为NFM 87.2%、AUS 7.1%、SFM 0.6%、MAL 5.0%。
- 各分类的恶性风险为NFM 0.3%、AUS 4.5%、SFM 66.7%、MAL 100%。
- 诊断性能指标为灵敏度95%、特异度100%、诊断准确率99%。
关键数值与推荐
- TIS分类标准:ND、NFM、AUS、SFM、MAL五类。
- 恶性风险:NFM 0.3%、AUS 4.5%、SFM 66.7%、MAL 100%。
- 诊断性能:灵敏度95%、特异度100%、准确率99%。
临床怎么用
- 脑脊液细胞学报告可采用TIS五分类术语进行标准化,并据此提供恶性风险分层。
- 对病因不明或既往有血液系统恶性肿瘤史者,建议细胞学联合流式细胞术以减少不确定诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cerebrospinal fluid (CSF) is an important diagnostic tool for detecting leptomeningeal involvement by malignancy or other etiologies. Currently, there is no standardized reporting system for CSF cytology. This study aims to assess the application of The International System for Serous Fluid Cytopathology (TIS) in categorizing CSF diagnoses and the role of flow cytometry in improving diagnostic performances. METHODS: CSF cases at our institution between January 1, 2023, and December 31, 2023, were reviewed and selected slides were examined. Based on the retrospective review of cytomorphologic findings and flow cytometry results, cases were reclassified into five diagnostic categories according to TIS: nondiagnostic (ND), negative for malignancy (NFM), atypia of uncertain significance (AUS), suspicious for malignancy (SFM), and malignant (MAL). RESULTS: The study cohort included 854 CSF cases from 439 patients. Flow cytometry was performed in 185 (21.7%) cases with a positive result in 23 cases. After applying TIS, final cytological diagnoses included NFM (87.2%), AUS (7.1%), SFM (0.6%), and MAL (5.0%). The calculated risk of malignancy was 0.3% for NFM, 4.5% for AUS, 66.7% for SFM, and 100% for MAL. The diagnostic performance metrics were 95% sensitivity, 100% specificity, and 99% diagnostic accuracy. CONCLUSIONS: The application of TIS to CSF specimens helps standardize reporting terminology, improves diagnostic accuracy, and offers predictive risk stratification. The conjunction with flow cytometry to CSF cytology helps reduce indeterminate diagnosis, especially for those with an uncertain etiology or prior history of hematological malignancy.
引用
- Wang M, Cai G. Application of The International System for Serous Fluid Cytopathology to cerebrospinal fluid and adjunct flow cytometry analysis improves diagnostic accuracy. Cancer Cytopathol. 2026. PMID: 42283197. doi:10.1002/cncy.70122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。